You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Drugs Containing Excipient (Inactive Ingredient) D&C RED NO. 27 ALUMINUM LAKE


✉ Email this page to a colleague

« Back to Dashboard


D&C RED NO. 27 ALUMINUM LAKE Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for D&C RED NO. 27 ALUMINUM LAKE

Introduction to D&C RED NO. 27 ALUMINUM LAKE

D&C RED NO. 27 ALUMINUM LAKE is a color additive commonly used in the pharmaceutical industry to impart a red color to various formulations. This excipient is crucial for the aesthetic appeal and branding of pharmaceutical products.

Market Size and Growth

The pharmaceutical excipients market, which includes color additives like D&C RED NO. 27 ALUMINUM LAKE, is experiencing significant growth. According to recent market reports, the global pharmaceutical excipients market is projected to grow from $9.7 billion in 2024 to $12.4 billion by 2029, at a compound annual growth rate (CAGR) of 5.1%[4].

Certification and Usage

The FDA plays a critical role in the certification of color additives, including D&C RED NO. 27 ALUMINUM LAKE. In the 4th quarter of the fiscal year 2024, the FDA certified 12,885.92 pounds of D&C RED NO. 27 ALUMINUM LAKE, with a total of 70,936.87 pounds certified from October 1 to September 30[1].

Quarterly and Annual Trends

  • Quarterly Trends: In the 3rd quarter of the fiscal year 2023, 9,021.78 pounds of D&C RED NO. 27 ALUMINUM LAKE were certified, indicating a steady demand for this excipient[2].
  • Annual Trends: The cumulative certification for D&C RED NO. 27 ALUMINUM LAKE from October to September shows a consistent increase, reflecting its stable and growing use in pharmaceutical formulations[1].

Market Drivers

Several factors drive the growth of the market for D&C RED NO. 27 ALUMINUM LAKE:

  • Robust Economic Development: Emerging markets with robust economic growth are driving the demand for pharmaceutical products, which in turn increases the need for excipients like D&C RED NO. 27 ALUMINUM LAKE[3].
  • Generic Drugs Market: The upswing in the market for generic drugs is another significant driver, as these drugs often require color additives to match brand-name counterparts[3].
  • Advanced Healthcare Infrastructure: The establishment of advanced healthcare infrastructure in various regions is also contributing to the increased demand for pharmaceutical excipients[3].

Competitive Landscape

The competitive landscape for pharmaceutical excipients, including D&C RED NO. 27 ALUMINUM LAKE, is highly competitive. Companies are focusing on mergers and acquisitions to strengthen their market position and expand their product portfolios. Additionally, there is a growing emphasis on sustainable packaging and reducing greenhouse gas emissions, which can influence the market dynamics[3].

Business Development Opportunities

For manufacturers of D&C RED NO. 27 ALUMINUM LAKE, several business development opportunities exist:

  • Identifying Potential Buyers: Access to detailed lists of drugs containing D&C RED NO. 27 ALUMINUM LAKE, along with company names and National Drug Codes (NDCs), can facilitate targeted marketing and sales efforts[5].
  • Offering Superior Alternatives: Companies can capitalize on the opportunity to introduce their premium products to companies that are yet to incorporate D&C RED NO. 27 ALUMINUM LAKE or are looking for alternatives[5].

Financial Trajectory

The financial trajectory for D&C RED NO. 27 ALUMINUM LAKE is closely tied to the overall growth of the pharmaceutical excipients market. Here are some key financial indicators:

  • Market Size: The total certified amount of D&C RED NO. 27 ALUMINUM LAKE, along with other excipients, contributes to the overall market size. In the fiscal year 2024, the total certified amount for all color additives was 20,175,055.27 pounds, indicating a substantial market[1].
  • Revenue Growth: The projected CAGR of 5.1% for the pharmaceutical excipients market from 2024 to 2029 suggests a steady revenue growth for manufacturers of D&C RED NO. 27 ALUMINUM LAKE[4].

Key Takeaways

  • Growing Demand: The demand for D&C RED NO. 27 ALUMINUM LAKE is driven by the expanding pharmaceutical industry and the need for color additives in drug formulations.
  • Certification Trends: FDA certification data indicates a consistent and growing use of D&C RED NO. 27 ALUMINUM LAKE.
  • Market Drivers: Robust economic development, the generic drugs market, and advanced healthcare infrastructure are key drivers of the market.
  • Business Opportunities: Manufacturers can identify potential buyers, offer superior alternatives, and focus on sustainable practices to enhance their market position.

FAQs

  1. What is the projected growth rate of the pharmaceutical excipients market?

    • The pharmaceutical excipients market is expected to grow at a CAGR of 5.1% from 2024 to 2029[4].
  2. How much D&C RED NO. 27 ALUMINUM LAKE was certified in the 4th quarter of FY 2024?

    • In the 4th quarter of FY 2024, 12,885.92 pounds of D&C RED NO. 27 ALUMINUM LAKE were certified[1].
  3. What are the key drivers of the market for pharmaceutical excipients?

    • Key drivers include robust economic development, the upswing in the generic drugs market, and the establishment of advanced healthcare infrastructure[3].
  4. How can manufacturers of D&C RED NO. 27 ALUMINUM LAKE identify potential buyers?

    • Manufacturers can use detailed lists of drugs containing D&C RED NO. 27 ALUMINUM LAKE, along with company names and NDCs, to target potential buyers[5].
  5. What are some trends in the pharmaceutical excipients market?

    • Trends include an emphasis on sustainable packaging, minimizing greenhouse gas emissions, and the use of artificial intelligence in supply chains[3].

Sources

  1. FDA Report on the Certification of Color Additives: 4th Quarter, Fiscal Year 2024
  2. FDA Report on the Certification of Color Additives: 3rd Quarter, Fiscal Year 2023
  3. Pharmaceutical Excipients Global Market Report 2024
  4. Excipients in Pharmaceuticals: Global Markets to 2029 - BCC Research
  5. D&C RED NO. 27 ALUMINUM LAKE Drug Excipient Business Development Opportunity Report, 2024 - DrugPatentWatch

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.